Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PATJ crumbs cell polarity complex component (PATJ) is a multi-PDZ domain-containing scaffold protein that is a central member of the apical Crumbs cell polarity complex, which also includes Crumbs (CRB3 in mammals) and PALS1. PATJ localizes to the tight junctions in epithelial cells and is essential for proper apicobasal polarity, organization of tight junctions, and directionality of epithelial cell migration. By serving as an adaptor protein, PATJ links the Crumbs complex to key signaling and structural proteins controlling junction assembly and cellular organization. While disruptions in PATJ or its partners lead to profound defects in epithelial polarity and tissue architecture, PATJ itself is not a current therapeutic target but is critical for understanding epithelial tissue biology and polarity-related diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PATJ crumbs cell polarity complex component (PATJ).